David Repaske, MD, PhD, Appointed Chief of Endocrinology, Metabolism and Diabetes at Nationwide Childrens Hospital

June 23, 2009

David Repaske, MD, PhD (43065), has been appointed chief of Endocrinology, Metabolism and Diabetes at Nationwide Childrens Hospital. In his role, Dr. Repaske will oversee a comprehensive range of services available in Endocrinology, Metabolism and Diabetes at Nationwide Childrens, including the evaluation and testing for diabetes and endocrine disorders. He also will have an appointment as director of the Division of Endocrinology and Metabolism in the Department of Pediatrics at The Ohio State University College of Medicine.

Former chief of Endocrinology, Juan Sotos, MD, will continue to serve as a physician in Endocrinology, Metabolism and Diabetes at Nationwide Childrens.

Dr. Repaske received his medical degree from Vanderbilt University School of Medicine (1985), and obtained his PhD in biochemistry from the University of Wisconsin-Madison (1980). He completed his residency at the University of North Carolina at Chapel Hill (UNC) in 1988, and his fellowships in human genetics at Vanderbilt (1986) and pediatric endocrinology at UNC (1991).

Previously a professor of pediatrics and member of the Neurosciences Training Program at the University of Cincinnati, Dr. Repaske directed the General Clinical Research Center Biochemistry Core Laboratory at Cincinnati and Cincinnati Childrens Hospital Medical Center. He also was associate director of the Pediatric Endocrinology Fellowship Training program at Cincinnati.

Dr. Repaske served as medical director of the Diabetes Center and was co-director of the interdisciplinary Disorders of Sexual Development Center at Cincinnati Childrens. He was highly involved with promoting quality and safety in clinical care, and served as physician leader of the Diabetes Quality Improvement Initiative, the Endocrinology Advanced Access Initiative and the Insulin Safety Taskforce at Cincinnati Childrens. 

Dr. Repaskes clinical research interests include the molecular basis of inherited diabetes insipidus, optimal therapy for congenital adrenal hyperplasia and innovations in care for diabetes and other chronic conditions.
 
Dr. Repaske is currently a member of the Scientific and Medical Programs Oversight Committee of the American Diabetes Association. He has published more than 20 peer review articles and nearly 50 chapters and abstracts.

About Nationwide Children's Hospital

Named to the Top 10 Honor Roll on U.S. News & World Report’s 2023-24 list of “Best Children’s Hospitals,” Nationwide Children’s Hospital is one of America’s largest not-for-profit free-standing pediatric health care systems providing unique expertise in pediatric population health, behavioral health, genomics and health equity as the next frontiers in pediatric medicine, leading to best outcomes for the health of the whole child. Integrated clinical and research programs, as well as prioritizing quality and safety, are part of what allows Nationwide Children’s to advance its unique model of care. Nationwide Children’s has a staff of more than 14,000 that provides state-of-the-art wellness, preventive and rehabilitative care and diagnostic treatment during more than 1.7 million patient visits annually. As home to the Department of Pediatrics of The Ohio State University College of Medicine, Nationwide Children’s physicians train the next generation of pediatricians and pediatric specialists. The Abigail Wexner Research Institute at Nationwide Children’s Hospital is one of the Top 10 National Institutes of Health-funded free-standing pediatric research facilities. More information is available at NationwideChildrens.org.